Dorman Products (DORM) is back on investors’ radar after recent trading left the stock around $117.02, with performance mixed between the past month and the past three months. Here is what current figures reveal.
See our latest analysis for Dorman Products.
Recent trading has pushed the 1 day share price return to 3.71% and the 1 month share price return to 4.88%. However, the year to date share price return is still down 5.71% and the 1 year total shareholder return has declined 7.44%, while the 3 year total shareholder return of 38.27% points to much stronger longer term momentum.
If you are comparing Dorman Products with other opportunities in the sector, it can help to look beyond a single stock and scan 34 power grid technology and infrastructure stocks
With recent returns mixed and the stock trading around $117.02, the question now is whether Dorman Products still offers value or if the current price already reflects the market’s expectations for future growth?
Most Popular Narrative: 23.3% Undervalued
The most followed narrative on Dorman Products currently points to a fair value of about $152.63 against the last close of $117.02. This frames the stock as materially undervalued based on long term cash flow expectations and margin assumptions.
The analysts have a consensus price target of $152.62 for Dorman Products based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $170.0, and the most bearish reporting a price target of just $140.0.
Want to see what underpins that gap between fair value and today’s price? The narrative leans heavily on earnings compounding, margin expansion and a tighter share count. The full story is in how those three inputs interact over time.
Result: Fair Value of $152.63 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, tariff uncertainty and the risk that large distributors push harder on pricing or terms could quickly challenge the current margin and cash flow narrative.
Find out about the key risks to this Dorman Products narrative.
Another Way To Look At Value
Our SWS DCF model presents a different perspective compared to the 23.3% undervalued narrative. From this standpoint, Dorman Products at $117.02 is trading above an estimated future cash flow value of $81.80, which suggests the stock may be expensive relative to that estimate. Which perspective do you think better reflects the risk you are taking?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Dorman Products for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
With sentiment clearly split in this article, now is the moment to review the data yourself and decide how comfortable you are with the trade off. To see what investors are optimistic about, check out the 2 key rewards
Looking for more investment ideas?
If you stop with just one stock, you might miss stronger fits for your goals, so use the screener to quickly surface ideas that match how you like to invest.
- Target income first by scanning companies with reliable payouts and yields that stand out using the 10 dividend fortresses.
- Spot quality at a discount by filtering for companies that combine strong fundamentals with reasonable prices through the 51 high quality undervalued stocks.
- Prioritise resilience by focusing on companies with sturdier balance sheets and lower risk profiles using the 67 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com